Efficacy and safety of camrelizumab in combination with radiation and chemotherapy for recurrent or metastatic cervical cancer

被引：0
|
作者：
Chen, Zhongjie
Yan, Bo
Xu, Liming
Huang, Xin
Li, Meng
Wang, Jun
Zhu, Li
Yuan, Zhiyong
Wang, Ping
机构：
[1] Tianjin Med Univ Canc Hosp & Inst, Tianjin, Peoples R China
[2] Tianjin Canc Hosp Airport Hosp, Tianjin, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5542
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Preliminary Efficacy and Safety of Camrelizumab in Combination With XELOX Plus Bevacizumab or Regorafenib in Patients With Metastatic Colorectal Cancer: A Retrospective Study
    Zhou, Hong
    Wang, Yuehui
    Lin, Yanfang
    Cai, Wenjie
    Li, Xiaofeng
    He, Xiaomeng
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [22] Efficacy and safety of camrelizumab combined with chemotherapy as second-line treatment for locally advanced, recurrent, or metastatic esophageal squamous cell carcinoma
    Yinfang Gu
    Xiaofang Zou
    Junlin Zhu
    Guowu Wu
    World Journal of Surgical Oncology, 23 (1)
  • [23] An Assessment of Combination of the Camrelizumab With Chemotherapy in Metastatic Biliary Tract Cancers
    Yu, Yi
    Huang, Shanshan
    Chen, Jun
    Yu, Feng
    Zhang, Lin
    Xiang, Xiaojun
    Deng, Jun
    Fang, Ziling
    Li, Junhe
    Xiong, Jianping
    CANCER CONTROL, 2021, 28
  • [24] Chemotherapy for recurrent, metastatic, or persistent cervical cancer: a systematic review
    Hirte, H. W.
    Strychowskyz, J. E.
    Oliverz, T.
    Fung-Kee-Fung, M.
    Elit, L.
    Oza, A. M.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2007, 17 (06) : 1194 - 1204
  • [25] The role of chemotherapy in locally advanced, metastatic and recurrent cervical cancer
    Tambaro, R
    Scambia, G
    Di Maio, M
    Pisano, C
    Barletta, E
    Iaffaioli, VR
    Pignata, S
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2004, 52 (01) : 33 - 44
  • [26] Exploring Effectiveness and Safety of Nimotuzumab in Recurrent or Metastatic Cervical Cancer
    Liu, Z.
    Zhang, J.
    Zhang, Q.
    Wang, J.
    Wang, T.
    Shi, F.
    Su, J.
    Wang, F.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : E259 - E259
  • [27] Efficacy, safety, and biomarker analysis of Camrelizumab in Previously Treated Recurrent or Metastatic Nasopharyngeal Carcinoma (CAPTAIN study)
    Yang, Yunpeng
    Zhou, Ting
    Chen, Xiaozhong
    Li, Jingao
    Pan, Jianji
    He, Xiaohui
    Lin, Lizhu
    Shi, Ying-rui
    Feng, Weineng
    Xiong, Jianping
    Yang, Kunyu
    Yu, Qitao
    Zhang, Qunling
    Hu, Desheng
    Sun, Yan
    Hu, Guangyuan
    Li, Ping
    Shen, Liangfang
    Lin, Qin
    Zhang, Ben
    Qu, Xiao
    Zou, Jianjun
    Zhang, Li
    Fang, Wenfeng
    Zhao, Yuanyuan
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (12)
  • [28] Efficacy of low dose nivolumab in recurrent / metastatic cervical cancer
    Devabhaktuni, S.
    Singh, A.
    Georgy, J. T.
    Antonisamy, J.
    Thumaty, D. B.
    John, A. O.
    ANNALS OF ONCOLOGY, 2023, 34 : S1585 - S1585
  • [29] Efficacy and Safety of Oxaliplatin, 5-Fluorouracil, and Folinic Acid Combination Chemotherapy as First-Line Treatment in Metastatic or Recurrent Gastric Cancer
    Kim, Han Jo
    Eun, Jun Young
    Jeon, Young Woo
    Yun, Jina
    Kim, Kyoung Ha
    Kim, Se Hyung
    Kim, Hyun Jung
    Lee, Sang-Cheol
    Bae, Sang Byung
    Kim, Chan Kyu
    Lee, Nam Su
    Lee, Kyu Taek
    Park, Seong-Kyu
    Won, Jong-Ho
    Hong, Dae Sik
    Park, Hee Sook
    CANCER RESEARCH AND TREATMENT, 2011, 43 (03): : 154 - 159
  • [30] Pembrolizumab with chemotherapy, with or without bevacizumab for persistent, recurrent, or metastatic cervical cancer
    McNamara, Blair
    Chang, Yifan
    Mutlu, Levent
    Harold, Justin
    Santin, Alessandro D.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2023, 23 (03) : 227 - 233
12345